Format

Send to

Choose Destination
Expert Opin Pharmacother. 2007 Apr;8(5):607-15.

New therapeutic strategies in the management of systemic sclerosis.

Author information

1
René Descartes University, Medical Faculty, Department of Rheumatology A, Cochin Hospital, Paris, France. yannick.allanore@cch.aphp.fr

Abstract

The pathogenic process of systemic sclerosis targets the skin and internal organs, and involves sequential or concomitant abnormalities in blood vessel function, immunity and subsequent fibroblast function. These characteristics are disease specific and may partly explain the unresolved therapeutic strategies that must take into account not only these various biological abnormalities, but also the complexities of the various abnormalities throughout the duration of the disease. However, recent epidemiological data have revealed a decrease in excess mortality, which may be mostly due to the use of cardiovascular drugs. This article deals with present and possible future therapeutic options.

PMID:
17376016
DOI:
10.1517/14656566.8.5.607
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center